New and sensitive HPLC-UV method for concomitant quantification of a combination of antifilariasis drugs in rat plasma and organs after simultaneous oral administration
| Autor: | Ismail, Patricia Layadi, Andi Dian Permana, Elly Wahyudin, Muh Raihan, Emilia Utomo, Muh. Nur Amir, Ryan F. Donnelly, Qonita Kurnia Anjani |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Biodistribution
General Chemical Engineering Administration Oral 030226 pharmacology & pharmacy 01 natural sciences High-performance liquid chromatography Analytical Chemistry Albendazole 03 medical and health sciences 0302 clinical medicine Ivermectin Pharmacokinetics Oral administration medicine Animals Humans Tissue Distribution Prospective Studies Rats Wistar Lymphatic filariasis Chromatography High Pressure Liquid Chromatography medicine.diagnostic_test Chemistry 010401 analytical chemistry General Engineering medicine.disease United States 0104 chemical sciences Rats Pharmaceutical Preparations Therapeutic drug monitoring medicine.drug |
| Zdroj: | Analytical methods : advancing methods and applications. 13(7) |
| ISSN: | 1759-9679 |
| Popis: | A combination treatment comprising ivermectin (IVM), albendazole (ABZ) and doxycycline (DOX) is often prescribed for lymphatic filariasis patients. Nevertheless, there has not been an analytical method established and documented to determine these compounds simultaneously. Herein, we report a new high-performance liquid chromatographic method coupled with a UV detector (HPLC-UV) to quantify these drugs in plasma and organs. This developed analytical method was validated according to the International Conference on Harmonization (ICH) and US Food and Drug Administration (FDA) guidelines. The validated method was successfully employed to analyze IVM, ABZ along with its metabolites (albendazole sulfoxide (ABZ-OX) and albendazole sulfone (ABZ-ON)), and DOX in the plasma and organs of Wistar rats after simultaneous oral administration. An Xselect CSH™ C18 HPLC column was utilized as a stationary phase, with a mobile phase consisting of 0.1% v/v trifluoracetic acid in water and acetonitrile with a run time of 20 min. The calibration curves in biological samples were found to be linear across the concentration range of 0.01-5 μg mL-1 for IVM, ABZ and ABZ metabolites, and 0.025-10 μg mL-1 for DOX with an R value ≥0.998 in each case. The validated method was found to be selective, precise and accurate. Finally, the method developed in this study was deployed to assess the pharmacokinetic profiles and biodistribution of the combination of drugs after oral administration to Wistar rats. The validated HPLC-UV method in this study provides an extensive range of prospective applications for pharmacokinetic-based studies, therapeutic drug monitoring and toxicology. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|